Clinical case description: A 61-year-old man with severe erectile dysfunction related to diabetes mellitus of long duration was treated through intracavernous stem cell application. Transplantation of autologous bone marrow stem cells through a single intracavernous injection was performed. Clinical response, Doppler ultrasound of the penis, and adverse events were evaluated during the 50-week follow-up. The highest clinical response was reported at week 12, but it diminished thereafter. At the end of follow-up, ultrasound identified the presence of neovascularization emerging from the cavernous arteries. Relevance: Numerous preclinical trials have demonstrated efficacy and safety, but there is insufficient clinical evidence showing promising results. Clinical implications: No adverse events were detected, and ultrasound revealed hemodynamic changes that were possibly related to the therapy. The source and dosage of stem cells, as well as subsequent therapeutic applications, pose questions that remain to be answered. Conclusions: Stem cell therapy for erectile dysfunction is a field of research that has sparked interest in numerous scientific groups, but clinical experience is still limited.
To describe the microbiological characteristics in emphysematous pyelonephritis (EPN), demonstrate the frequency of extended-spectrum beta-lactamase (ESBL) microorganisms, and determine if these microorganisms are associated with the prognosis of patients with EPN. We conducted a retrospective study in patients with a diagnosis of EPN in a tertiary care hospital of the northeast region of Mexico during the period from January 2011 to January 2016. Clinical variables were analyzed to determine association with the presence of ESBL-producing microorganisms. Statistical significance was set with p<0.05. A total of 63 patients were included; 55 (87.3%) of them were females, with a median age of 55 (interquartile range: 45–65) years. Conservative management was indicated in 38.1%; 42.9% were treated with ureteral stent; 12.7% with open or percutaneous drainage; 15.8% with early nephrectomy; and 9.5% with delayed nephrectomy. Reported mortality was 13 (20.6%) cases; 23 (36.5%) cases required admission to the intensive care unit. The most frequent microorganism isolated was Escherichia coli (n=34, 53.9%). ESBL microorganisms were found in 31.7% of the population. No significant association of ESBL was found with admission to the intensive care unit, or with increased mortality. To our knowledge, this is the first study that evaluates ESBL microorganisms as a prognostic factor in EPN. Risk factors associated with a poor prognosis in patients with EPN have been described. The microbiological factors, specifically ESBL-producing bacteria, do not seem to influence in the prognosis of these patients.
Objetivo: Describir los agentes causales, la prevalencia de resistencia a antibióticos y determinar factores de riesgo asociados con agentes productores de betalactamasa de espectro extendido (BLEE) en las infecciones del tracto urinario (ITU). Materiales y métodos: Realizamos una cohorte retrospectiva en un hospital de III Nivel en Monterrey, México. Se incluyeron pacientes con clínica de ITU de marzo a octubre del 2017 con urocultivo positivo. Se determinó la asociación con agentes productores de BLEE, utilizando la prueba Χ2 para variables categóricas y la prueba T para variables continuas. La significancia estadística se estableció en p <0.05 utilizando SPSS versión 20.0. Resultados: 353 urocultivos positivos fueron recabados. La producción de BLEE se encontró en 21.5%. Altas resistencias a amoxicilina-clavulanato (75%) y moderada resistencia a gentamicina, aztreonam, ceftriaxona, ciprofloxacina, levofloxacina, fosfomicina y trimetoprima-sulfametoxazol fueron encontradas. Los agentes BLEE se asociaron con ITU complicada (p = <0.0001) y se asociaron con DM2 (p = 0.02), inmunodeficiencia (p = 0.008), radioterapia (p = 0.025) y uso previo de antibióticos (p = <0.001). Limitaciones: La relación clonal de los aislamientos, especialmente de E. coli, no se analizó. No podemos establecer si hubo diversidad genética entre los aislamientos y si ocurrió adquisición independiente o transmisión cruzada. Valor: Evaluamos las características epidemiológicas de los agentes productores de BLEE en ITU en un hospital de III Nivel de México. Conclusiones: Una de cada cinco ITU es causada por agentes BLEE en nuestra población. Existe una alta resistencia a los antibióticos usados como terapia empírica en nuestra población.
Objective: To describe the causal agents, prevalence of antimicrobial resistance, and risk factors associated with extended spectrum beta-lactamase (ESBL)-producing agents in urinary tract infections (UTIs). Materials and methods: A retrospective study was conducted at a tertiary care hospital in Monterrey, Mexico. Inclusion criteria were patients that clinically presented with a UTI and had a positive urine culture, within the time frame of March to October 2017. The association with ESBL-producing agents was determined through the Χ2 test for categorical variables. Statistical significance was set at a p 50%) to amoxicillin-clavulanate, ciprofloxacin, levofloxacin, fosfomycin, and trimethoprim-sulfamethoxazole and moderate resistance (10-50%) to gentamicin and ceftriaxone. Amikacin, ertapenem, nitrofurantoin, and colistin had the lowest resistance rates (
Case description: The objective of this study is to describe the robot-assisted Madigan technique and report our initial experience in three cases with benign prostatic hyperplasia who underwent simple robot-assisted prostatectomy with this technique. No major complications were reported in the included cases. An improvement in urinary symptoms and preservation of ejaculatory and erectile function were demonstrated in all patients during their follow-up. Relevance: Simple prostatectomy and endourological procedures for the management of benign prostatic hyperplasia continue to have the disadvantage of presenting inevitable adverse effects, such as ejaculatory disorders. The Madigan technique for simple prostatectomy is an alternative that allows to preserve the prostatic urethra and bladder neck in order to avoid ejaculatory. Clinical implications: The robot-assisted Madigan technique is a therapeutic option that should be considered in a young patient with obstructive prostatic growth who wishes to preserve ejaculatory function after surgical treatment. Conclusions: Prospective studies are required to compare the different simple prostatectomy techniques to validate the role of this technique in the preservation of ejaculation.
Clinical case description: A 61-year-old man with severe erectile dysfunction related to diabetes mellitus of long duration was treated through intracavernous stem cell application. Transplantation of autologous bone marrow stem cells through a single intracavernous injection was performed. Clinical response, Doppler ultrasound of the penis, and adverse events were evaluated during the 50-week follow-up. The highest clinical response was reported at week 12, but it diminished thereafter. At the end of follow-up, ultrasound identified the presence of neovascularization emerging from the cavernous arteries. Relevance: Numerous preclinical trials have demonstrated efficacy and safety, but there is insufficient clinical evidence showing promising results. Clinical implications: No adverse events were detected, and ultrasound revealed hemodynamic changes that were possibly related to the therapy. The source and dosage of stem cells, as well as subsequent therapeutic applications, pose questions that remain to be answered. Conclusions: Stem cell therapy for erectile dysfunction is a field of research that has sparked interest in numerous scientific groups, but clinical experience is still limited.